↓ Skip to main content

A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma

Overview of attention for article published in Clinical Cancer Research, September 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
patent
45 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
186 Dimensions

Readers on

mendeley
123 Mendeley